Company Analysis
Sign in

Firefly Neuroscience, Inc. (AIFF)

Nasdaq: AIFF · Services-Prepackaged Software · Kenmore, NY · filing with the SEC since 1995
Full chart Alerts Compare
Grade3.2
◀ Past 1.1● Present 1.2▶ Future 6.2
2 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

The grade of Firefly Neuroscience, Inc.

Nine metrics read from its own filings, by tense
Headline grade
3.2/10
◀ Past1.125% of the headline
● Present1.235% of the headline
▶ Future6.240% of the headline

All three tenses have at least two readings, so the archetype blend applies as printed.

Of the nine metrics, 7 read as filed from the record and 2 are SI estimates, each with its reasoning, its confidence and what would change it on its card.

◀ Past

What did they actually do?

1.1/1025% of the headline grade · 2 of 3 filed, 1 estimated

Surviving crises

as filed
0.8/10

Has it survived what it has been through?

14 warning events since 2017; the latest 2025-04-01.

weight 22% of this tense · 8th percentile among 230 sector filers · read for itself

From the record

Firefly Neuroscience, Inc.'s filings since 2017 show 14 warning events of 3 kinds: a notice about its exchange listing (8-K item 3.01, 4 times, the latest 2024-08-12); an auditor change (8-K item 4.01, 3 times, the latest 2024-11-01); a late-report notice (Form NT 10-K or NT 10-Q, 7 times, the latest 2025-04-01) (its current reports).

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Track record

as filed
1.7/10

What has it actually done, year after year?

-13.7% a year over 10 filed years; profitable in 2 of 10.

weight 45% of this tense · 17th percentile among 213 sector filers · read for its customers

From the record

Firefly Neuroscience, Inc.'s 10 filed years say what it did: revenue went from $6 million in fiscal 2014 to $1 million in fiscal 2025, down 13.7% a year; it rose in 5 of 9 years; the deepest fall was 99% from fiscal 2021 to fiscal 2024; net income was positive in 2 of 10 of those years (its annual reports).

What it rests on

  • revenue growth over the filed span-13.7%bottom 3% of its family
  • the share of years revenue rosebottom 17% of its family
  • the share of filed years with a profitbottom 46% of its family
  • the deepest fall from a revenue peak99.3%bottom 1% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Shareholder treatment

SI estimate
0.6/10

How has it treated the people who own it?

SI estimate 0.6/10, confidence 35 of 100 (one part).

weight 33% of this tense · 6th percentile among 216 sector filers · read for its shareholders

SI estimate Inferred, not read as filed

Why it is an estimate
Read from one part only, the share count over the years, which ranks in the bottom 6% of 216 in its family; fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income.
What the record cannot read
Fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income.
How it was reasoned
one part: the share count over the years, the one part on file, ranked among 216 in its family.
Confidence
35 of 100
What would change it
A filing that carries the missing parts replaces this estimate with the filed reading.

From the record

SI estimate, not a filed reading: Firefly Neuroscience, Inc.'s shareholder treatment is put at 0.6 of 10 with a confidence of 35 of 100, because read from one part only, the share count over the years, which ranks in the bottom 6% of 216 in its family; fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income. A filing that carries the missing parts replaces this estimate with the filed reading.

● Present

What are they doing right now?

1.2/1035% of the headline grade · 2 of 3 filed, 1 estimated

Financial health

as filed
2.4/10

Is it financially healthy right now?

ROE -260%: lost 260¢ per shareholder dollar. Leverage 27%: owes 27¢ per asset dollar.

weight 45% of this tense · 24th percentile among 217 sector filers · read for itself

From the record

Return on equity: in the fiscal year ended 2025-12-31, Firefly Neuroscience, Inc. lost about 260 cents for every dollar of shareholders' money, and gross profitability: its products earned about 6 cents per dollar of everything the company owns. Leverage: it owed about 27 cents per dollar of assets, and net share issuance: its share count grew 90.1% over the year (the filed statements).

What it rests on

  • what it owes per dollar of assetstop 24% of its family
  • return on equitybottom 3% of its family
  • gross profit against assetsbottom 8% of its family
  • the share count against the year beforebottom 11% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Industry position

as filed
0.3/10

How strong is its position in its industry?

bottom 3% of 218 in its family; net margin -1741%.

weight 33% of this tense · 3rd percentile among 218 sector filers · read for its customers

From the record

Firefly Neuroscience, Inc.'s standing among 218 graded names in its industry family: revenue of $1 million in fiscal 2025 ranks in the bottom 4% by size; a net margin of -1741% ranks in the bottom 3%; revenue growth of -54.4% a year over the last 3 filed years ranks in the bottom 1% (its annual reports).

What it rests on

  • revenue against the family$1.1Mbottom 4% of its family
  • net margin-1741.0%bottom 3% of its family
  • three-year revenue growth-54.4%bottom 1% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Leadership

SI estimate
0.0/10

What are the people in charge doing?

SI estimate 0.0/10, confidence 35 of 100 (one part).

weight 22% of this tense · 0th percentile among 167 sector filers · read for its shareholders

SI estimate Inferred, not read as filed

Why it is an estimate
Read from one part only, officer and director changes on Form 8-K over three years, against the people in charge, which ranks in the bottom 1% of 167 in its family; the record of its people begins on 2025-03-12 (a listing, a merger or a first filing under the rules) and its chief executive and most of the people in charge have filed since then, so the record shows a floor of 1.7 years and cannot see past it; a floor under five years is not read as years in charge.
What the record cannot read
The record of its people begins on 2025-03-12 (a listing, a merger or a first filing under the rules) and its chief executive and most of the people in charge have filed since then, so the record shows a floor of 1.7 years and cannot see past it; a floor under five years is not read as years in charge.
How it was reasoned
one part: officer and director changes on Form 8-K, against the people in charge, the one part on file, ranked among 167 in its family.
Confidence
35 of 100
What would change it
A filing that carries the missing parts replaces this estimate with the filed reading.

From the record

SI estimate, not a filed reading: Firefly Neuroscience, Inc.'s leadership is put at 0.0 of 10 with a confidence of 35 of 100, because read from one part only, officer and director changes on Form 8-K over three years, against the people in charge, which ranks in the bottom 1% of 167 in its family; the record of its people begins on 2025-03-12 (a listing, a merger or a first filing under the rules) and its chief executive and most of the people in charge have filed since then, so the record shows a floor of 1.7 years and cannot see past it; a floor under five years is not read as years in charge. A filing that carries the missing parts replaces this estimate with the filed reading.

▶ Future

What are they set up to do next?

6.2/1040% of the headline grade · 3 of 3 filed

Room to expand

as filed
4.3/10

How much room does it have to grow?

bottom 43% of 216 in its family for room to expand.

weight 22% of this tense · 43rd percentile among 216 sector filers · read for itself

From the record

Firefly Neuroscience, Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash from operations less capital spending is -717.5% of revenue (bottom 3%); a gross margin of 56.5% (bottom 31%); research spending of 129.8% of revenue (top 6%) (its annual report).

What it rests on

  • cash from operations less capital spending against revenue-717.5%bottom 3% of its family
  • gross margin56.5%bottom 31% of its family
  • research spending against revenue129.8%top 6% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Growth drivers

as filed
6.6/10

What could actually drive growth from here?

top 34% of 213 in its family for growth drivers.

weight 45% of this tense · 66th percentile among 213 sector filers · read for its customers

From the record

Firefly Neuroscience, Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew -54.4% a year over the last three filed years against -13.7% over all 10, slowing (bottom 4% of its family); the newest year grew 959.1% (top 1%); research spending grew 41.4% a year (top 7%) (its annual reports). Firefly Neuroscience, Inc. tags no split of its revenue by line in the annual report on file, so growth by line cannot be read here; research and capital spending are on the trend.

What it rests on

  • three-year growth against the whole span-40.7 points a yearbottom 4% of its family
  • the newest year's revenue growth959.1%top 1% of its family
  • three-year growth of research spending41.4%top 7% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Expectations vs reality

as filed
7.0/10

Did its newest year beat what its own record pointed to?

top 30% of 194 in its family for expectations against reality.

weight 33% of this tense · 70th percentile among 194 sector filers · read for its shareholders

From the record

Firefly Neuroscience, Inc.'s newest year against its own record: revenue of $1 million in fiscal 2025 came in 11038.7% above the $10 thousand its prior three years' pace pointed to (top 1% of its family); net income of $20 million against a prior three-year average of $10 million (bottom 12%); a net margin of a loss larger than its revenue against losses larger than its revenue before (top 1%) (its annual reports).

What it rests on

  • revenue against the prior three years' pace11038.7%top 1% of its family
  • net income against the prior three years' average-94%bottom 12% of its family
  • net margin against its prior averageup more than 100 pointstop 1% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

The grade is the company against its own industry, from its filings. It is not a view on the share price. How the grade is made

SI Assistanton AIFF · research, not advice